Geron presentations Tue on telomerase inhibitors

Geron will present preclinical data related to imetelstat, the company's telomerase inhibitors. April 3rd, the results will be posted on there website. Results must be good. If not why do a presentation. Also they want the ok to be able sell 100 million more share. If results are looking good, the share price will go up and Geron sells some shares. Making money for phase 3 trials. Closed  $1.69 on 868,708 shares. The 10 day avg. volume is 538,615.  The three month avg volume is 1 million shares.
I think the presentation will move this share price up. Lets see if I'm right.

Good luck in this rigged casino,